Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Beyond Extranodal Site Count: Clinical and Anatomical Characterization of Primary Multifocal Extranodal Diffuse Large B‐Cell Lymphoma. Local targets link to admitted publications; unresolved targets remain external evidence.
An Enhanced International Prognostic Index (NCCN‐IPI) for Patients With Diffuse Large B‐Cell Lymphoma Treated in the Rituximab Era
10.1182/blood-2013-09-524108 · 2014 · External reference
A Predictive Model for Aggressive Non‐Hodgkin's Lymphoma
10.1056/nejm199309303291402 · 1993 · External reference
Multifocal Extranodal Non‐Hodgkin Lymphoma: A Clinicopathologic Study of 37 Cases in Greece, a Hellenic Cooperative Oncology Group Study
10.1634/theoncologist.10-9-734 · 2005 · External reference
Sites of Extranodal Involvement Are Prognostic in Patients With Diffuse Large B‐Cell Lymphoma in the Rituximab Era: An Analysis of the Surveillance, Epidemiology and End Results Database
10.1002/ajh.23638 · 2014 · External reference
Diffuse Large B‐Cell Lymphoma: Clinical Implications of Extranodal Versus Nodal Presentation – A Population‐Based Study of 1575 Cases
10.1046/j.1365-2141.2003.04749.x · 2004 · External reference
Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence
10.1007/s11864-018-0555-8 · 2018 · External reference
Extranodal Diffuse Large B‐Cell Lymphoma: Clinical and Molecular Insights With Survival Outcomes From the Multicenter EXPECT Study
10.1002/cac2.70033 · 2025 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
FactoMineR: An R Package for Multivariate Analysis
2008 · External reference
Unresolved reference
External reference
Primary Extranodal Non‐Hodgkin's Lymphoma (NHL): The Impact of Alternative Definitions Tested in the Comprehensive Cancer Centre West Population‐Based NHL Registry
10.1093/annonc/mdg004 · 2003 · External reference
Modified Number of Extranodal Involved Sites as a Prognosticator in R‐CHOP‐Treated Patients With Disseminated Diffuse Large B‐Cell Lymphoma
10.3904/kjim.2010.25.3.301 · 2010 · External reference
Extranodal Site of Diffuse Large B‐Cell Lymphoma and the Risk of R‐CHOP Chemotherapy Resistance and Early Relapse
2020 · External reference
Extranodal Involvement in Young Patients With Diffuse Large B‐Cell Lymphoma: Distribution, Prognostic Value and Treatment Options
10.21147/j.issn.1000-9604.2017.01.07 · 2017 · External reference
Prognostic Impact of Extranodal Involvement in Diffuse Large B‐Cell Lymphoma in the Rituximab Era
10.1002/cncr.27381 · 2012 · External reference
Clinical Features and Outcomes of Diffuse Large B‐Cell Lymphoma Based on Nodal or Extranodal Primary Sites of Origin: Analysis of 1,085 WHO Classified Cases in a Single Institution in China
10.21147/j.issn.1000-9604.2019.01.10 · 2019 · External reference
Diffuse Large B‐Cell Lymphoma: Sites of Extranodal Involvement Are a Stronger Prognostic Indicator Than Number of Extranodal Sites in the Rituximab Era
10.3109/10428194.2014.982636 · 2015 · External reference
Influence of Organ‐Specific Extranodal Involvement on Survival Outcomes in Stage IV Diffuse Large B‐Cell Lymphoma
10.1002/cam4.70565 · 2025 · External reference
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma With Therapeutic Implications
10.1016/j.ccell.2020.03.015 · 2020 · External reference
Influence of Oncogenic Mutations and Tumor Microenvironment Alterations on Extranodal Invasion in Diffuse Large B‐Cell Lymphoma
10.1002/ctm2.221 · 2020 · External reference
